A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
Clinical trial NCT03914352 · UNKNOWN
Trial details
- NCT number
- NCT03914352
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2019-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.